According to the results, costunolide could relieve the inflammation and fibrosis in two murine AIH models, and the therapeutic effect might work by suppressing the activation of PI3K-AKT pathway and inhibiting the phosphorylation of SRC and IGF1R. Here, SRC is linked to autoimmune hepatitis.